Thermo Fisher Scientific to Buy Affymetrix in $1.3 Billion Cash Deal

Thermo Fisher Scientific Inc. will buy Affymetrix Inc. in a roughly $1.3 billion cash deal that would boost its biogenetic analysis portfolio, the company said Friday.

from WSJ.com: US Business http://ift.tt/1ZbsNgR
via IFTTT